🧐Attending #EHA2024 and interested in Multiple Myeloma?
Check out poster 851 for new insights on epigenetic regulation in Myeloma
🚨Spoiler alert: NRF1 (Nuclear Respiratory Factor 1) plays a pivotal role in regulating Myeloma progression! #myeloma#epigenetic#cancer
if you're interested in learning about Multiple Myeloma and epigenetics, join me at poster 851 at #EHA2024. Let's discuss gene regulation and its impact on myeloma. See you there! #myeloma#gene_regulation
ERC-funded positions now open❗️❕❗️
Join the @GiuntaLab to understand human DNA evolution through the study of satellite repeats 🧬🧫🔬
APPLY here:
https://t.co/8cUYCV8YET
Pls RT 🔄🗨️🙏
This afternoon, I will present a poster (spoiler below) at the #EACR23. If you are interested and would like to discuss about Multiple myeloma, epigenetic and transcription factors regulation, I'll be happy to meet you there! 💻🖼️
@EACRnews@IREISGufficiale
The opening day of my first #EACR23 conference has come to a close!
The talks were incredibly fascinating, the new insights on #CRISPR technologies and methods of investigating Circulating Tumor Cells had me fully engaged.
Excited and ready for an incredible week ahead!💡🔬💻
Had an incredible opportunity to train at a bioinformatics school in Novi Sad organized by @bioinform_org ! 🌟
Hoping that sharing our knowledge and work experience will inspire these young minds to pursue a career in bioinformatics💻
#bioinform#bioinformingtheyouth
📯Application are open!
🎟️If you're a BSc student who's interested in learning about Bioinformatics and exploring its potential as a future career, you absolutely have to join this school.
#Bioinformatics#bioinform#school
Ready to be #Bioinformed?
The call for applications for our two new training schools is now open!
𝗪𝗵𝗲𝗿𝗲: Novi Sad and Skopje
𝗪𝗵𝗲𝗻: 24-28th April, 8-12th May
𝗪𝗵𝗼: BSc students
𝗪𝗵𝗮𝘁: Bioinformatics and Career paths
Visit https://t.co/SDvYMNRotS for applying.
Interested in single cell genomics but need help getting started? Check out my lab's Single Cell Genomics Day on April 7. Talks will feature recent exciting computational and experimental advances and will be livestreamed at https://t.co/zG98gkckMU. Please RT/spread the word!
🇮🇹Lavorare con colleghi che si mettono in gioco sempre è una fortuna da non sottovalutare!
Congratulazioni @StefanoDiggio 🥳
🇬🇧Working with colleagues who always challange themselves is a fortune not to be underestimated!
Grazie alla commissione per aver riconosciuto positivamente il mio lavoro. Questo premio è una grande motivazione per continuare su questa strada! @Nana_ETS
Here we demonstrate how epistatic interaction between KEAP1 mutations and associated copy number alterations reduce immunotherapy efficacy sustaining a COLD immune microenvironment. Thanks to all the contributors, incredible scientific journey, and interdisciplinary effort!
Super excited to see my first graphical #abstract on the #cover of @JTOonline!
The latest review by @stescalera & @MaugeriSacca about the molecular functions of the KEAP1-NRF2 pathway, its role in #lungcancer and how KEAP1/NFE2L2 mutations reduce the efficacy of treatments💊
A few days ago Computational Biology Summer School ended!
Amazing experience, several opportunities to enlarge my research network and have great scientific conversations. And last but not least a lot of fun and new researcher friends!@UCLA_CGSI #CGSI2022#research#epigenetic
Very excited that our paper "Discovering the drivers of clonal hematopoiesis", with Iker Reyes-Salazar, @abel_gonzalezp, @nlbigas is out!!
https://t.co/m5Q0tkTJVV
Tweetorial 👉🏾(1/n)
@bbglab@IRBBarcelona
#MedicinaPersonalizzata, il Valore della Ricerca: La cura giusta per il paziente giusto nel momento giusto grazie al DNA tumorale.
🧬💊A ogni alterazione genomica può essere associato un farmaco specifico!
👉🏻meno effetti collaterali e terapie non necessarie
➕ qualità di vita
Interested in single cell genomics but need help getting started? Check out the full agenda for our Single Cell Genomics Day next Friday (3/4). All talks will be live-streamed (no registration required) at https://t.co/vKIvFdsWzs